Notably, most clinical investigations studied women (1404 female versus 83 male participants), which is expected since estrogen declines after age 30 years, and further estrogen decline with aging represents health challenges, as well as a reduction in QOL [9, 10, 19,20,21,22] and a degradation in the most visible organ of the bodythe skin [9, 10]
Demonstrating efficacy in obesity-related comorbidities will be paramount in order to achieve reimbursement in Europe, yet it will take time for trials focused on these co-morbidities to translate into label expansion and revenues
Trc khi quyt nh b sung L-glutathione, bn cn thc hin kim tra tng qut v tham kho kin ca bc s c liu lng ph hp vi c nhn
Shedding light on the effects of calorie restriction and its mimetics on skin biology